Does hypophosphataemia induce hypoparathyroidism in pre-dialysis patients?

Nephrology Dialysis Transplantation

Volumn 13, Issue SUPPL. 3, 1998, Pages 12-14

  Carvalho, Aluizio B ^a,b   Lobao, Roselia R S ^a   Cuppari, Lilian ^a   Draibe, Sergio A ^a   Ajzen, Horacio ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

Calcitriol; Hypoparathyroidism; Hypophosphataemia; Low phosphorus intake; Pre dialysis; PTH

Indexed keywords

CALCITRIOL; PARATHYROID HORMONE; PHOSPHORUS;

BIOCHEMISTRY; BONE BIOPSY; CONFERENCE PAPER; DIET SUPPLEMENTATION; DIETARY INTAKE; HUMAN; HYPOPARATHYROIDISM; HYPOPHOSPHATEMIA; KIDNEY FAILURE; NUTRITION; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL;

EID: 0031968931     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/13.suppl_3.12     Document Type: Conference Paper

References (18)

1. Slatopolsky E, Caglar S, Gradowska L, Canterbury JM et al. On the prevention of secondary hyperparathyroidism in experimental chronic renal disease using 'proportional reduction' of dietary phosphorus intake. Kidney Int 1972; 2: 147-151
2. Lopez-Hilker S, Dusso A, Rapp N et al. Phosphorus restriction reverses hyperparathyroidism in uremia independent of changes in calcium and calcitriol. Am J Physiol 1990; 259: F432-F437
3. Ritz E, Stefanski A, Rambausek M. The role of the parathyroid glands in the uremic syndrome. Am J Kidney Dis 1995; 26: 808-813
4. Portale AA, Booth BE, Halloran BP et al. Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency. J Clin Invest 1984; 73: 1580-1589
5. Sherrard DJ, Hercz G, Pei Y et al. The spectrum of bone disease in end-stage renal failure - an evolving disorder. Kidney Int 1993; 43: 436-442
6. Hercz G, Pei Y, Greenwood C et al. Aplastic osteodystrophy without aluminum: the role of 'suppressed' parathyroid function. Kidney Int 1993; 44: 860-866
7. Wang M, Hercz G, Sherrard DJ et al. Relationship between intact 1-84 parathyroid hormone and bone histomorphometric parameters in dialysis patients without aluminum intoxication. Am J Kidney Dis 1995; 26: 836-844
8. Bover J, Jara A, Trinidad P et al. The calcemic response to PTH in the rat: effect of elevated PTH levels and uremia. Kidney Int 1994; 46: 310-317
9. Cohen-Solal ME, Sebert JL, Boudailliez B et al. Non-aluminic adynamic bone disease in non-dialyzed uremic patients: a new type of osteopathy due to overtreatment? Bone 1992; 13: 1-5
10. Carvalho AB, Jorgetti V, Cendoroglo Neto M et al. High incidence of adynamic bone disease (ABD) in chronic renal failure predialysis (CRF) patients (abstract). Nephrol Dial Transplant 1992; 7: 755
11. Adler AJ, Berlyne GM. Phosphate retention and the genesis of secondary hyperparathyroidism. Am J Nephrol 1986; 6: 417-421
12. Silver J, Moallem E, Epstein E et al. New aspects in the control of parathyroid hormone secretion. Curr Opin Nephrol Hypertension 1994; 3: 379-385
13. Lopez-Hilker S, Galceran T, Chan YL et al. Hypocalcemia may not be essential for the development of secondary hyperparathyroidism in chronic renal failure. J Clin Invest 1986; 78:1097-1102
14. Linhares ER, Jones DA, Round JM et al. Effect of nutrition on vitamin D status: studies on healthy and poorly nourished Brazilian children. Am J Clin Nutr 1984; 39: 625-630
15. Lobao R, Carvalho A, Cuppari L et al. Low turnover bone disease (LTBD) detected by bone densitometry in predialysis chronic renal failure (PDRF) patients (abstract), J Am Soc Nephrol 1996; 7: 1793
16. Hernandez D, Concepcion MT, Lorenzo V et al. Adynamic bone disease with negative aluminium staining in predialysis patients: prevalence and evolution after maintenance dialysis. Nephrol Dial Transplant 1994; 9: 517-523
17. Coen G, Mazzaferro S, Ballanti P et al. Renal bone disease in 76 patients with varying degrees of predialysis chronic renal failure: a cross-sectional study. Nephrol Dial Transplant 1996; 11: 813-819
18. Cuppari L, Carvalho A, Lobao R et al. Hormonal responses to oral phosphorus (P) supplementation in pre-dialysis patients (PRD) with low levels of PTH or adynamic bone disease (ABD) (abstract). J Am Soc Nephrol 1996; 7: 1788